Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06293469 · ClinicalTrials.gov registry record · NA

Accelerated Flap Coverage in Severe Lower Extremity Trauma

A NA study of Open Tibia Fracture and Open Dislocation of Ankle, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
356
Enrollment target
9
Study locations

NCT06293469: Recruiting NA study of Open Tibia Fracture and Open Dislocation of Ankle, sponsored by Johns Hopkins University.

NCT06293469 is a NA study of Open Tibia Fracture and Open Dislocation of Ankle that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 356 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06293469, a NA study of Open Tibia Fracture and Open Dislocation of Ankle, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
356 participants
Enrollment target
9
Study locations

Study Summary

The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with open fractures and/or dislocations below the knee. Eligible patients will be randomized to receive either a flap within a goal of 72 hours of injury or standard of care flap timing for the institution. The primary outcome will be a composite outcome to evaluate clinical status 6 months after randomization. Components of the composite outcome will be hierarchically assessed in the following order: 1) all-cause mortality, 2) amputation related to injury, 3) re-operation for infection and/or flap complication (flap compromise, partial and/or complete flap failure), and 4) days in hospital, defined as days in an acute in-patient hospital (i.e., not rehab or nursing facility).

Primary Outcome

Clinical status is a hierarchical composite of the following outcomes: 1. All-cause mortality 2. Amputation related to injury 3. Re-operation for infection and/or flap complication (flap compromise, partial and/or complete flap failure) 4. Days in hospital, defined as days in an acute in-patient hospital (i.e., not rehab or nursing facility)

Interventions

  • PROCEDURE Accelerated Flap Coverage Surgery
  • PROCEDURE Standard of Care Flap Timing

Study Locations (9)

Maryland

  • R Adams Cowley Shock Trauma Center - Baltimore
  • John Hopkins Bayview Medical Center - Baltimore
  • The Johns Hopkins Hospital - Baltimore
  • University of Maryland Capital Region Medical Center - Largo

California

  • UC Davis Medical Center - Sacramento

Oregon

  • Oregon Health & Science University - Portland

Tennessee

  • Vanderbilt University Medical Center - Nashville

Victoria

  • The Alfred Hospital - Melbourne

Other

  • Vall d'Hebron University Hospital - Barcelona

Trial Details

FieldValue
Enrollment Target 356 participants
Start Date 2024-11-04
Est. Completion 2030-02
Phase NA
Johns Hopkins University

1,448 total trials

What NCT06293469 shows while recruiting

NCT06293469 is an interventional study that assigns participants to a tested intervention. The registered 356 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 4 conditions, with Open Tibia Fracture appearing as the primary indexed condition, and to 2 interventions - of which Accelerated Flap Coverage Surgery is the first listed.

NCT06293469 lists 9 locations in 6 states (Maryland, California, Oregon).

Frequently Asked Questions

What is clinical trial NCT06293469 about?

NCT06293469 is a clinical study titled "Accelerated Flap Coverage in Severe Lower Extremity Trauma". The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with open fractures and/or dislocations below the knee. Eligible patients will be randomized to receive ei...

What is the current status of trial NCT06293469?

This trial is currently recruiting. It is a NA study. The enrollment target is 356 participants. The study started on 2024-11-04. Estimated completion is 2030-02.

What conditions does trial NCT06293469 study?

This clinical trial studies the following conditions: Open Tibia Fracture, Open Dislocation of Ankle, Extremity Fracture Lower, Extremity Injuries Lower.

What interventions are being tested in trial NCT06293469?

The interventions under investigation include: Accelerated Flap Coverage Surgery (PROCEDURE), Standard of Care Flap Timing (PROCEDURE).

Who is sponsoring clinical trial NCT06293469?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06293469 being conducted?

This trial has 9 study locations across California, Maryland, Oregon, Tennessee, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Open Tibia Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06293469's enrollment target sits among peer trials

356 291st of 2000 higher than 1,710 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06077838 · 356 participants · NA

    RELAXaHEAD for Headache Patients (Phase III)

  • NCT06958328 · 356 participants · Phase 3

    Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • NCT06960993 · 356 participants · NA

    Mosaic Trial for Stem Cell Transplant Recipients

  • NCT06062888 · 357 participants · Phase 2

    FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06293469, the US trial registry maintained by the National Library of Medicine. NCT06293469 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.